News
Videos
Conferences
Events
Resources
Subscribe

Opinion|Videos|May 1, 2024

Current First-Line Treatment Options in CLL

Focusing on the first-line setting, Yuliya Linhares, MD, gives an overview of first-line treatment options for patients with chronic lymphocytic leukemia.

Episodes in this series

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 1 Understanding a CLL Diagnosis

Yuliya P.L Linhares, MD, an expert on CLL

EP. 2 Diagnostic Tests in CLL

Video 3 - "Goals of Treatment for Patients With CLL"

EP. 3 Goals of Treatment for Patients With CLL

Video 4 - "Current First-Line Treatment Options in CLL"

EP. 4 Current First-Line Treatment Options in CLL

Yuliya P.L Linhares, MD, an expert on CLL

EP. 5 Factors That Guide CLL Treatment Decisions

Josie Montegaard, MSN, AGPCNP-BC, an expert on CLL

EP. 6 What to Expect from Treatment

Video 7 - "Overview of Efficacy and Safety Data for Current CLL Treatment Options"

EP. 7 Overview of Efficacy and Safety Data for Current CLL Treatment Options

Video 8 - "Acalabrutinib-Based Treatment Clinical Trial Updates"

EP. 8 Acalabrutinib-Based Treatment Clinical Trial Updates

Yuliya P.L Linhares, MD, an expert on CLL

EP. 9 Venetoclax-Based Treatment Clinical Trial Updates

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 10 Zanubrutinib-Based Treatment Clinical Trial Updates

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 11 Ibrutinib-Based Treatment Clinical Trial Updates

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 12 Newer Combinations for the Treatment of CLL

Josie Montegaard, MSN, AGPCNP-BC, an expert on CLL

EP. 13 What to Know Before Starting Your CLL Treatment

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 14 An Overview of Potential Treatment Adverse Effects

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 15 Treatment Decisions in R/R CLL

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 16 Shared Decision-Making and Supportive Care in the CLL Treatment Journey

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 17 Optimizing Overall Health During CLL Management

Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL

EP. 18 Getting the Most From Your CLL Care Team

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Treatment Goals in Metastatic EGFR-Positive NSCLC, Advocacy Resources, and Closing Thoughts

ByKartik Konduri, MD,Lynn Abbott-McCloud,Elizabeth Dennis, MSN, APRN, FNP-C

July 21st 2026

Frontline and Subsequent Treatment Planning for Metastatic EGFR-Positive NSCLC

ByKartik Konduri, MD,Lynn Abbott-McCloud,Elizabeth Dennis, MSN, APRN, FNP-C

July 14th 2026

Quality-of-Life Considerations During Treatment for Metastatic EGFR-Positive NSCLC

ByKartik Konduri, MD,Lynn Abbott-McCloud,Elizabeth Dennis, MSN, APRN, FNP-C

July 14th 2026

Practical Considerations, Logistical Burdens, and Support Resources for Metastatic EGFR-Positive NSCLC

ByKartik Konduri, MD,Lynn Abbott-McCloud,Elizabeth Dennis, MSN, APRN, FNP-C

July 7th 2026

Treatment Landscape of Late-Stage Metastatic EGFR-Positive NSCLC, Side Effect Education, and Shared Decision-Making

ByKartik Konduri, MD,Lynn Abbott-McCloud,Elizabeth Dennis, MSN, APRN, FNP-C

July 7th 2026

Trending on CURE

Breast Cancer Treatments Awaiting FDA Decisions: 4 to Watch

6 Cancer Drugs FDA Approved in August 2026 and What They Mean for You

FDA Approves Etcamah Plus CDK4/6 Inhibitor for ESR1-Mutated Breast Cancer

T-Cell Therapies Offer New Ways to Treat Lung Cancer

Prostate Cancer Treatments in the FDA Pipeline: What Could Come Next